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Introduction 
Cluster of differentiation 14 (CD14) was described as 
monocyte/ macrophage differentiation antigen on the 
surface  of  myeloid  lineage,  such  as  monocytes, 
macrophages and dendritic cells (DCs).
1 This protein 
plays  a  crucial  role  in  the  immune  recognition  and 
reactivation in microbial cell wall components from 
Gram-positive and Gram-negative bacteria.
2 Recently, 
CD14  role  is  known  in  phagocytic  clearance  of 
apoptotic cells.
3 CD14 isoforms, 52-55 kDa expressed 
on  the  surfaces  of  monocytes  and  neutrophils  are 
attached  to  the  cell  surface  by  a  glycosyl 
phosphatidylinositol (GPI) anchor, membrane protein 
(mCD14) and the serum soluble 48–56 kDa (sCD14, 
an  acute  phase  protein).
4  Soluble  CD14  found  in 
human serum has been attributed to the shedding of 
mCD14  from  monocytes,  macrophages  and  PMN. 
Membrane CD14 as a receptor for lipopolysaccharide 
(LPS)  on  the  membrane  of  the  mononuclear 
phagocyte (MPS) binds to LPS-binding protein (LBP) 
in  plasma  and  transfers  to  the  cell  surface  receptor 
CD14.
5 It has been commonly used in normal tissue 
or  blood  and  in  leukemia  as  a  marker  for  myeloid 
cells. LPS stimulates the human monocytes activation 
via  several  intracellular  signaling  pathways  that 
involves the proinflammatory factors.
6 
On the cell surface, CD14 associates with Toll-like 
receptor  4  (TLR4).  Binding  of  the  LPS  and  LPS-
binding  protein  complex  to  CD14  induces  signal 
transduction through TLR4, which then triggers the 
synthesis and release of proinflammatory chemokine 
(IP10),  and  cytokines  (TNF-α,  IL-6  and  IL-1).
7,8 
CD14 Expression on myeloid cell line can be induced. 
Among  several  myeloid  cell  lines  (HL60,  THP-1, 
Mononomac-  1,  and  U937),  U937  cells  and  HL-60 
cells are the most frequently used as valid model for 
investigating  monocytic  differentiation  and 
consequent biological functions of differentiated cells 
in vitro. U937 cells of histocytic lymphoma basis are 
arrested  in  a  more  advanced  step  of  differentiation 
(promonocyte/monocyte).
9  HL-60  human  leukemia 
cells can be induced to differentiation into monocyte, 
macrophage  and  granulocytes  by  inducing  factors. 
Various stimuli [LPS (lipopolysaccharide), Dimethyl 
Sulfoxide  (DMSO),  1,  25-dihydroxyvitamin  D3 
[1,25(OH)2D3], either alone or in combination, have 
been recognized that have an effect on the level of 
CD14  expression  in  the  human  HL-60  and  human 
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Purpose: CD14, one of the main differentiation markers on the surface of myeloid 
lineage  cells,  acts  as  a  key  role  in  activation  of  LPS-induced  monocytes.  LPS 
(lipopolysaccharide) binds to LPS-binding protein in plasma and are delivered to the 
cell  surface  receptor  CD14.  In  this  study,  Various  stimuli  [Dimethyl  Sulfoxide 
(DMSO), active 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and LPS], either alone or 
in  combination,  have  been  recognized  that  have  an  effect  on  the  level  of  CD14 
expression in the human HL-60 and U937 promonocytic cell lines and therefore induce 
their terminal differentiation into monocytes or mature macrophages. Methods: U937 
and HL-60 cells were cultured in RPMI 1640 supplemented with 10% FBS. For each 
cell line, 1×10
6 cells were seeded for 72 hours with DMSO, 14 days with LPS and 18 
days with 1, 25-D3 in each well plate; then ELISA method was used to study their 
responses to the factors by means of anti-CD14. Results: ELISA assay demonstrated 
that U937 and HL-60 cells were induced by both [1,25(OH)2D3] and DMSO to obtain 
characteristics of adherent cells and express CD14 protein; moreover, LPS at a low 
dose increased CD14 expression on surface of this cells. Conclusion: According to the 
our results, it is speculated that CD14 gene expression may be induced in human U937 
and HL-60 cell lines by different factors including 1,25-D3, DMSO and LPS.  
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U937  promonocytic  cell  lines  and  therefore  induce 
their  terminal  differentiation  into  monocytes  or 
mature  macrophages.
10  Upon  differentiation,  U937 
cells  gain  a  large  range  of  macrophage  function 
through  the  concerted  expression  of  several  genes. 
Differentiated  U937  cells  can  be  further  stimulated 
with  LPS  to  mimic  inflammatory  response  of 
activated macrophages.
11 In this study, U937 and HL-
60 model system was employed to express monocyte-
macrophage  differentiation  patterns.  LPS  1,  25-
Dihydroxyvitamin  D3  [1,25(OH)2D3]  and  DMSO 
were  used  for  inducing  monocytic-macrophage 
differentiation of the U937 and HL-60 leukemic cell 
lines in a dose- and time dependent manner. It have 
been investigated that this maturation mimics the in 
vivo monocytic or myeloid differentiation. 
 
Material and Methods 
Cell Preparation and Seed 
U937  and  HL-60  cell  lines  were  purchased  from 
Pasteur Institute of Iran (cell Bank).  The cells were 
grown  and  maintained  in  a  humidified  incubator  at 
37°C  and  in  5%  CO2  atmosphere.  RPMI-1640 
medium (SIGMA) was supplemented with 15% heat 
inactivated Fetal Bovine Serum (FBS), 100 units/mL 
penicillin,  2.5  ml  amphotericin  B,  5×  10  M  2-
mercaptoethanol and 2.5 mM L-glutamine,  and 100 
𝜇g/mL streptomycin (all from Invitrogen Gibco) were 
used  for  cell  cultures.  Upon  reaching  appropriate 
confluence, the  cells  were passaged  every  2-3  days 
and seeding was at in initial concentration of 1× 10
6 
cell/ml. LPS (Escherichia coli O111: B4) and 1,25-D3 
were purchased from sigma chemical company. Five 
well  of  12-well  flat-bottom  culture  plates  (Nunc, 
Denmark) were seeded per cell line. 1×10
6 cells per 
well was incubated and treated with DMSO + LPS for 
14 days, 0.1 µmol 1,25-D3 , 1000 ng/ ml LPS for 18 
days,  and  with  LPS  +  Vitamin  D3  for  18  day, 
respectively. 
 
Microscopic Analysis 
Morphological  changes  after  5-6  days  incubation, 
maturation  and  morphology  differentiation  into 
macrophage-monocyte  was  detected  by  light 
microscopic analysis. 
 
ELISA Assay 
CD14  protein  expression  on  cell  membrane  was 
analyzed  by  ELISA  assay.  Briefly,  after  incubation 
period, 1 × 10
6 cell was seeded in 12-well flat-bottom 
ELISA plate. Glotaraldehid 25% was used to fix the 
suspended cells into bottom of ELISA plate wells for 
12-16 hour in 4°C. After the overnight incubation, the 
plates  were  washed  3  times  with  PBS  containing 
0.05%  (v/v)  Tween  20  (PBS-T).  Each  well  was 
blocked  with  200  μL  of  PBS  containing  1%  (w/v) 
BSA (Sigma) for 1 h at room temperature and washed 
3  times  with  PBS-T.  Subsequently  100  µl  of  first 
antibody  (mouse  anti-human  CD14  /monoclonal 
antibodies: 1/1000 diluted in PBS buffer), was added 
and incubated for 2 hour in 37°C, and washed 3 times 
with PBS-T. Secondary antibody (rabbit anti-mouse 
IgG  conjugated  to  horseradish  peroxidase 1/3000 
diluted in PBS buffer) was added to each well and 
incubated for 1 hour at 37 °C. 100 µL of 0.01% (w/v) 
3,  3’,  5,  5’  tetramethylbenzidine  (TMB) 
chromogenic/substrate solution (Sigma) was added to 
each well. The reaction was stopped by adding 50 μL 
of  2  N  sulfuric  acid,  yielding  a  yellow  color.  The 
optical density (OD) colored solution was quantified 
at  450  nm  wavelengths  by  using  an  enzyme  linked 
immunoabsorbent assay reader (ELISA Reader, Bio-
Rad). 
 
Results 
The morphological changes of cells were examined by 
light  microscopy.  After  5-6  days  incubation,  it  was 
exposed that cells gained pseudopods and shift from a 
round  shape  to  a  macrophage-like  morphology. 
Adhesion shapes were seen in treated cells. Figure 1 
demonstrates  that  cells  completed  the  macrophage-
monocyte differentiation characteristics. 
 
 
Figure 1. Morphology of U937 cells. A) Control, B) DMSO, C) 
1, 25-D3 and D) LPS treated cells. The LPS, DMSO, and 1, 
25-D3  effect  on  Differentiation  of  U937  cells  shift  from  a 
round  shape  to  a  macrophage-like  morphology,  from 
suspension  to  adhesion  growth  and  acquire  phagocytic 
activity with amoeboid morphology.  
 
The expression of CD14 molecule in the membrane of 
U937  and  HL-60  cells  was  detected  using  ELISA 
assay by mouse monoclonal antibodies against human 
CD14  to  confirmed  Differentiation  of  the  cells. 
ELISA analysis explained that expression of CD14 in 
cells surface significantly enhance by treatment with 
DMSO  +  LPS,  [1,25(OH)2D3],  LPS,  DMSO,  and 
with LPS + [1,25(OH)2D3], altogether. As Figure 2 
shows,  LPS  and  LPS  +  [1,25(OH)2D3]  treatment, 
determined the highest expression of CD14 in HL-60 
cell  line  but  DMSO  group  showed  little  CD14 
expression in U937 and HL-60 cells.  
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Induction of CD14 Expression 
 
Figure 2. ELISA analysis, expression of CD14 in cells surface 
was  significantly  enhanced  by  treatment  with  DMSO  +  LPS, 
[1,25(OH)2D3],  LPS,  DMSO,  and  with  LPS  + 
[1,25(OH)2D3], altogether. 
 
Discussion 
Human U937 promonocytic and HL-60 leukemic cell 
lines as the precursors of the mononuclear phagocyte 
system are the important cell line to study the cells shift 
from  a  round  shape  to  a  macrophage-like 
morphology.
12 In addition, CD14 protein expression in 
membrane  of  HL-60  is  slight  too.  Furthermore, 
[1,25(OH)2D3] and DMSO can induce U937 and HL-
60  cells  expressing  the  CD14,  and  make  them  take 
reaction to the stimulation of LPS. The result of this 
study showed that the way inducing U937 and HL-60 
to  express  CD14  protein  is  a  stable,  reliable  and 
practicable method, and it can satisfy the demand of 
experiments.
13  U937  cells  can  be  induced  to 
differentiation by a large number of substances (TPA, 
retinoic acid, DMSO, Zn++ and low concentration of 
glutamine).  In  their  differentiated  stage,  these  cells 
assume  a  typical  macrophage  aspect,  adhere  to 
substrate, and change morphology: they assume a more 
irregular  flat  shape  with  long  pseudopodia  and 
cytoplasmic  protrusions,  and  acquire  phagocytic 
capability.
14 [1,25(OH)2D3] is an important regulator 
of  inducing  differentiation  and  proliferation  of  many 
cells, and it can induce U937 cells to express CD14 
protein.  Some  researchers  have  reported  that 
[1,25(OH)2D3]  can  induce  40%  of  U937  cells  to 
express CD14 protein in 8 hours and the percentage of 
cells  expressing  CD14  protein  reached  100%  in  24 
hours.
15,16 
Sun et al found that some intermediated molecular are 
required in the process of inducing U937 cell to express 
the CD14 gene, shown by [1,25(OH)2D3] using FCM, 
Northern  blotting  and  run-on  transcription  analysis. 
They  detected  the  inducing  process  needed  for  the 
synthesis of new protein called SP1, and found that the 
sequencing  U937  cell  to  express  CD14  protein  by 
[1,25(OH)2D3].
16 Baek et al reported that retinoic acid 
could  increase  the  expression  of  CD14  in  U937  cell 
after  [1,25(OH)2D3]  treatment.  This  aspect  needs 
further  study.  The  present  study,  induction  of  CD14 
membrane  expression  with  different  stimuli  was 
assayed  in  vitro.  LPS,  DMSO  and  [1,25(OH)2D3], 
alone  and  together  as  inducers  of  U937  and  HL-60 
differentiation were compared and then found that LPS 
and LPS + [1,25(OH)2D3] groups treatment expressed 
the highest amount of CD14.
17 
 
 
 
Conclusion 
According to the our results, it is speculated that CD14 
gene expression may be induced in human U937 and 
HL-60  cell  lines  by  different  factors  including 
[1,25(OH)2D3], and LPS. 
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